← Leaderboards
Hany Elmariah
H. Lee Moffitt Cancer Ctr & Res Inst
$729,140
Attributed
$729,140
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $250K · FY2018–22$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$729,140 · 1
By mechanism
R01$729,140 · 1
Top collaborators
No co-investigators on record.
Grant awards (3)
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)$239,390
R01 · FY2022 · FD · contact PI
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)$239,750
R01 · FY2021 · FD · contact PI
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)$250,000
R01 · FY2018 · FD · contact PI